Press release
July 23, 2026
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
Ardelyx, Inc. (ARDX)
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX) (“Ardelyx” or the “Company”), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet